Literature DB >> 15849504

Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas.

Jingbo Qiao1, Junghee Kang, Jeremy Cree, B Mark Evers, Dai H Chung.   

Abstract

OBJECTIVES: To evaluate whether aggressive, undifferentiated neuroblastomas express tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) and to examine the effects of gastrin-releasing peptide (GRP) on PTEN gene and protein expression. SUMMARY BACKGROUND DATA: We have previously shown that neuroblastomas secrete GRP, which binds to its cell surface receptor (GRP-R) to stimulate cell growth in an autocrine fashion. However, the effects of GRP on expression of the tumor suppressor gene PTEN have not been elucidated in neuroblastomas.
METHODS: Paraffin-embedded sections from human neuroblastomas were analyzed for PTEN and phospho-Akt protein expression by immunohistochemistry. Human neuroblastoma cell lines (SK-N-SH and SH-SY5Y) were stably transfected with the plasmid pEGFP-GRP-R to establish GRP-R overexpression cell lines, and the effects of GRP on PTEN gene and protein expression were determined.
RESULTS: A decrease in the ratio of PTEN to phospho-Akt protein expression was identified in poorly differentiated neuroblastomas. An increase in GRP binding capacity was confirmed in GRP-R overexpressing cells, which demonstrated an accelerated constitutive cell growth rate. PTEN gene and protein expression was significantly decreased in GRP-R overexpressing cells when compared with controls.
CONCLUSIONS: Our findings demonstrate decreased expression of the tumor suppressor protein PTEN in more aggressive undifferentiated neuroblastomas. An increase in GRP binding capacity, as a result of GRP-R overexpression, down-regulates PTEN expression. These findings suggest that an inhibition of the tumor suppressor gene PTEN may be an important regulatory mechanism involved in GRP-induced cell proliferation in neuroblastomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849504      PMCID: PMC1357123          DOI: 10.1097/01.sla.0000161173.47717.71

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  34 in total

1.  PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.

Authors:  Muxiang Zhou; Lubing Gu; Harry W Findley; Rong Jiang; William G Woods
Journal:  Cancer Res       Date:  2003-10-01       Impact factor: 12.701

2.  Breast cancer--loss of PTEN predicts resistance to treatment.

Authors:  Pier Paolo Pandolfi
Journal:  N Engl J Med       Date:  2004-11-25       Impact factor: 91.245

3.  Gastrin-releasing peptide is a growth factor for human neuroblastomas.

Authors:  Sunghoon Kim; Wanqin Hu; David R Kelly; Mark R Hellmich; B Mark Evers; Dai H Chung
Journal:  Ann Surg       Date:  2002-05       Impact factor: 12.969

Review 4.  Molecular biology of neuroblastoma.

Authors:  J M Maris; K K Matthay
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

5.  Insulin-like growth factor I stimulates motility in human neuroblastoma cells.

Authors:  G E Meyer; E Shelden; B Kim; E L Feldman
Journal:  Oncogene       Date:  2001-11-08       Impact factor: 9.867

6.  Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

Authors:  Anjali K Gupta; W Gillies McKenna; Charles N Weber; Michael D Feldman; Jeffrey D Goldsmith; Rosemarie Mick; Mitchell Machtay; David I Rosenthal; Vincent J Bakanauskas; George J Cerniglia; Eric J Bernhard; Randal S Weber; Ruth J Muschel
Journal:  Clin Cancer Res       Date:  2002-03       Impact factor: 12.531

Review 7.  The p53 pathway and its inactivation in neuroblastoma.

Authors:  Deborah A Tweddle; Andrew D J Pearson; Michelle Haber; Murray D Norris; Chengyuan Xue; Claudia Flemming; John Lunec
Journal:  Cancer Lett       Date:  2003-07-18       Impact factor: 8.679

8.  Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor.

Authors:  Vivian Wai Yan Lui; Sufi Mary Thomas; Qing Zhang; Abbey Lynn Wentzel; Jill Marie Siegfried; Joyce Yan Li; Jennifer Rubin Grandis
Journal:  Oncogene       Date:  2003-09-18       Impact factor: 9.867

9.  Differential expression of the PTEN tumor suppressor protein in fetal and adult neuroendocrine tissues and tumors: progressive loss of PTEN expression in poorly differentiated neuroendocrine neoplasms.

Authors:  Luoquan Wang; Ana Ignat; Constantine A Axiotis
Journal:  Appl Immunohistochem Mol Morphol       Date:  2002-06

10.  Bombesin antagonists inhibit proangiogenic factors in human experimental breast cancers.

Authors:  A M Bajo; A V Schally; K Groot; K Szepeshazi
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

View more
  20 in total

1.  Targeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas.

Authors:  Pritha Paul; Lauren A Gillory; JungHee Kang; Jingbo Qiao; Dai H Chung
Journal:  Surgery       Date:  2010-10-29       Impact factor: 3.982

2.  Inhibition of transforming growth factor-beta/Smad signaling by phosphatidylinositol 3-kinase pathway.

Authors:  Jingbo Qiao; Junghee Kang; Tien C Ko; B Mark Evers; Dai H Chung
Journal:  Cancer Lett       Date:  2006-01-18       Impact factor: 8.679

3.  miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis.

Authors:  Jingbo Qiao; Sora Lee; Pritha Paul; Lauren Theiss; Joshua Tiao; Lan Qiao; Andrew Kong; Dai H Chung
Journal:  Surgery       Date:  2013-06-24       Impact factor: 3.982

4.  Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells.

Authors:  Titilope A Ishola; JungHee Kang; Jingbo Qiao; B Mark Evers; Dai H Chung
Journal:  Biochim Biophys Acta       Date:  2007-02-20

Review 5.  Gastrin-releasing peptide links stressor to cancer progression.

Authors:  Xinqiu Li; Yunfu Lv; Aihua Yuan; Zongfang Li
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-06       Impact factor: 4.553

6.  Integrin β1 is critical for gastrin-releasing peptide receptor-mediated neuroblastoma cell migration and invasion.

Authors:  Sora Lee; Jingbo Qiao; Pritha Paul; Dai H Chung
Journal:  Surgery       Date:  2013-08       Impact factor: 3.982

7.  Ets1 transcription factor mediates gastrin-releasing peptide-induced IL-8 regulation in neuroblastoma cells.

Authors:  Jingbo Qiao; Jung-Hee Kang; Jeremy Cree; B Mark Evers; Dai H Chung
Journal:  Neoplasia       Date:  2007-03       Impact factor: 5.715

8.  Gastrin-releasing peptide expression and its effect on the calcification of developing mouse incisor.

Authors:  Dong-Joon Lee; Chengri Jin; Eun-Jung Kim; Jong-Min Lee; Han-Sung Jung
Journal:  Histochem Cell Biol       Date:  2015-07-01       Impact factor: 4.304

9.  Single-walled carbon nanotube-mediated small interfering RNA delivery for gastrin-releasing peptide receptor silencing in human neuroblastoma.

Authors:  Jingbo Qiao; Tu Hong; Honglian Guo; Ya-Qiong Xu; Dai H Chung
Journal:  Methods Mol Biol       Date:  2013

10.  Differential regulation of cyclin-dependent kinase inhibitors in neuroblastoma cells.

Authors:  Lan Qiao; Pritha Paul; Sora Lee; Jingbo Qiao; Yongsheng Wang; Dai H Chung
Journal:  Biochem Biophys Res Commun       Date:  2013-04-22       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.